Comparison · NSE · data 2026-11-02
Q-Line Biotech Limited vs Sahajanand Medical Technologies Limited
In plain words
Size: Sahajanand Medical Technologies Limited is about 3.9 times the market value of Q-Line Biotech Limited.
Differences in the numbers, not a recommendation of either stock.
Side by side
| QLINE | SMT | |
|---|---|---|
| Price | ₹507 | ₹456.5 |
| Market cap | ₹1,196 cr | ₹4,675 cr |
| P/E | — | — |
| P/B | — | — |
| ROE | 25.6% | — |
| ROCE | 27.9% | — |
| Debt / equity | 0.92 | — |
| Operating margin | — | — |
| Dividend yield | 0.00% | 0.00% |
| Sales growth, 3 years (yearly) | 23.2% | — |
| Profit growth, 3 years (yearly) | 20.2% | — |
| 1-year return | 12.2% | 23.0% |
| Revenue, last 12 months | — | — |
| Net profit, last 12 months | — | — |
| Latest quarter | — | — |
| Quarter net profit | — | — |
| Quarter profit vs a year earlier | — | — |
| Promoter holding | — | — |
| Health check | Strong (7.6/10) | Strong (6.9/10) |